Professor Emmanouil Tsochatzis

Job title

Professor and honorary consultant in hepatology



GMC Number


Contact details

Email address:

PA/secretary phone number: 020 7794 0500 ext 33575

PA/secretary email address:

Related services

Liver services


Emmanouil Tsochatzis is a Professor of hepatology at UCL and a honorary consultant at the Sheila Sherlock Liver Centre. He is the head of the Centre for Metabolic Liver disease in the UCL Institute for Liver and Digestive Health and a member of the governing board of the European Association for the Study of the Liver. His clinical and research interests are in NAFLD, cirrhosis and portal hypertension and metabolic liver disease (Wilsons disease and iron disorders).


  • Tsochatzis E, Crossan C, Longworth L, Gurusamy K, Rodriguez-Peralvarez M, Mantzoukis K, O’Brien J, Thalassinos E, Papastergiou V, Noel-Storr A, Davidson B, Burroughs AK «Cost-effectiveness of non-invasive liver fibrosis tests for treatment decisions in patients with chronic hepatitis C», Hepatology 2014; In Press
  • Tsochatzis E, Bruno S, Isgro G, Hall A, Theocharidou E, Manousou P, Dhillon AP, Burroughs AK, Luong TV «Collagen proportionate area is superior to other histological methods for sub-classifying cirrhosis and determining prognosis», J Hepatol 2014;60: 948-54
  • Tsochatzis EA, Bosch J, Burroughs AK «Liver cirrhosis», The Lancet, 2014;383: 1749-61
  • Tsochatzis E, Bosch J, Burroughs AK «Future treatments of liver cirrhosis», Expert reviews in Gastroenterology and Hepatology 2014; 8:571-81
  • Papastergiou V, Tsochatzis E, Pieri G, Thalassinos E, Dhar A, Bruno S, Karatapanis S, Luong TV, O’Beirne J, Patch D, Thorburn D, Burroughs AK «Nine scoring models for short term mortality in alcoholic hepatitis: a cross validation in a biopsy proven cohort», Alimentary Pharmacology and Therapeutics 2014; 39:721-32
  • Rodriguez-Peralvarez M, Tsochatzis E, Naveas MC, Pieri G, Garcia-Caparros C, O’Beirne J, Poyato-Gonzales A, Ferrin-Sanchez G, Montero-Alvarez JL, Patch D, Thorburn D, Briceno J, De la Mata M, AK Burroughs  «Reduced exposure to calcineurin inhibitors early after liver transplantation prevents recurrence of hepatocellular carcinoma», Journal of Hepatology 2013; 59:1193-9
  • Tsochatzis E, Garcovich M, Marelli L, Papastergiou V, Fatourou E, Rodriguez-Peralvarez ML, Germani G, Davies N, Yu D, Luong TV, Dhillon AP, Thorburn D, Patch D, O’Beirne J, Meyer T, Burroughs AK «Transarterial embolization as neo-adjuvant therapy pretransplantation in patients with hepatocellular carcinoma», Liver International 2013; 33:944-9
  • Papastergiou V, Burroughs AK, Tsochatzis EA «Prognosis and treatment of patients with acute alcoholic hepatitis», Expert reviews in Gastroenterology and Hepatology 2014; 8:471-86
  • Manousou P, Cholongitas E, Samonakis D, Tsochatzis E, Corbani A, Dhillon AP, Davidson J, Rodríguez-Perálvarez M, Patch D, O'Beirne J, Thorburn D, Luong T, Rolles K, Davidson B, McCormick PA, Hayes P, Burroughs AK. «Reduced fibrosis in recurrent HCV with tacrolimus, azathioprine and steroids versus tacrolimus: randomised trial long term outcomes» Gut. 2014; 63: 1005-13
  • Papastergiou V, Tsochatzis E, Rodriguez-Peralvarez M, Thalassinos E, Pieri, G, Manousou P, Germani G, Rigamonti C, Arvaniti V, Karatapanis S, Burroughs AK «Biochemical criteria at one year are not robust indicators of response to ursodeoxycholic acid in primary biliary cirrhosis: results from a 29-year cohort study», Alimentary, Pharmacology & Therapeutics 2013; 38:1354-64